273 related articles for article (PubMed ID: 31234952)
1. G protein-coupled estrogen receptor-1 agonist induces chemotherapeutic effect via ER stress signaling in gastric cancer.
Lee SJ; Kim TW; Park GL; Hwang YS; Cho HJ; Kim JT; Lee HG
BMB Rep; 2019 Nov; 52(11):647-652. PubMed ID: 31234952
[TBL] [Abstract][Full Text] [Related]
2. G-Protein-Coupled Estrogen Receptor (GPER)-Specific Agonist G1 Induces ER Stress Leading to Cell Death in MCF-7 Cells.
Vo DH; Hartig R; Weinert S; Haybaeck J; Nass N
Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31540491
[TBL] [Abstract][Full Text] [Related]
3. SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.
Santolla MF; Avino S; Pellegrino M; De Francesco EM; De Marco P; Lappano R; Vivacqua A; Cirillo F; Rigiracciolo DC; Scarpelli A; Abonante S; Maggiolini M
Cell Death Dis; 2015 Jul; 6(7):e1834. PubMed ID: 26225773
[TBL] [Abstract][Full Text] [Related]
4. Regulation of ERRalpha gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: differential molecular mechanisms mediated by g protein-coupled receptor GPR30/GPER-1.
Li Y; Birnbaumer L; Teng CT
Mol Endocrinol; 2010 May; 24(5):969-80. PubMed ID: 20211987
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer.
Liu Q; Chen Z; Jiang G; Zhou Y; Yang X; Huang H; Liu H; Du J; Wang H
Mol Cancer; 2017 May; 16(1):87. PubMed ID: 28476123
[TBL] [Abstract][Full Text] [Related]
6. GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo.
Chimento A; Sirianni R; Casaburi I; Zolea F; Rizza P; Avena P; Malivindi R; De Luca A; Campana C; Martire E; Domanico F; Fallo F; Carpinelli G; Cerquetti L; Amendola D; Stigliano A; Pezzi V
Oncotarget; 2015 Aug; 6(22):19190-203. PubMed ID: 26131713
[TBL] [Abstract][Full Text] [Related]
7. GPER-induced signaling is essential for the survival of breast cancer stem cells.
Chan YT; Lai AC; Lin RJ; Wang YH; Wang YT; Chang WW; Wu HY; Lin YJ; Chang WY; Wu JC; Yu JC; Chen YJ; Yu AL
Int J Cancer; 2020 Mar; 146(6):1674-1685. PubMed ID: 31340060
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER.
Zekas E; Prossnitz ER
BMC Cancer; 2015 Oct; 15():702. PubMed ID: 26470790
[TBL] [Abstract][Full Text] [Related]
9. GPER mediates activation of HIF1α/VEGF signaling by estrogens.
De Francesco EM; Pellegrino M; Santolla MF; Lappano R; Ricchio E; Abonante S; Maggiolini M
Cancer Res; 2014 Aug; 74(15):4053-64. PubMed ID: 24894716
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth.
Catalano S; Giordano C; Panza S; Chemi F; Bonofiglio D; Lanzino M; Rizza P; Romeo F; Fuqua SA; Maggiolini M; Andò S; Barone I
Breast Cancer Res Treat; 2014 Jul; 146(2):273-85. PubMed ID: 24928526
[TBL] [Abstract][Full Text] [Related]
11. The activation of the G protein-coupled estrogen receptor (GPER) inhibits the proliferation of mouse melanoma K1735-M2 cells.
Ribeiro MPC; Santos AE; Custódio JBA
Chem Biol Interact; 2017 Nov; 277():176-184. PubMed ID: 28947257
[TBL] [Abstract][Full Text] [Related]
12. G protein-coupled estrogen receptor (GPER) expression in endometrial adenocarcinoma and effect of agonist G-1 on growth of endometrial adenocarcinoma cell lines.
Skrzypczak M; Schüler S; Lattrich C; Ignatov A; Ortmann O; Treeck O
Steroids; 2013 Nov; 78(11):1087-91. PubMed ID: 23921077
[TBL] [Abstract][Full Text] [Related]
13. GPER activates Notch signaling in breast cancer cells and cancer-associated fibroblasts (CAFs).
Pupo M; Pisano A; Abonante S; Maggiolini M; Musti AM
Int J Biochem Cell Biol; 2014 Jan; 46():56-67. PubMed ID: 24275097
[TBL] [Abstract][Full Text] [Related]
14. GPER mediates decreased chemosensitivity via regulation of ABCG2 expression and localization in tamoxifen-resistant breast cancer cells.
Yu T; Cheng H; Ding Z; Wang Z; Zhou L; Zhao P; Tan S; Xu X; Huang X; Liu M; Peng M; Qiu YA
Mol Cell Endocrinol; 2020 Apr; 506():110762. PubMed ID: 32087276
[TBL] [Abstract][Full Text] [Related]
15. G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
Liu C; Liao Y; Fan S; Tang H; Jiang Z; Zhou B; Xiong J; Zhou S; Zou M; Wang J
Med Oncol; 2015 Apr; 32(4):104. PubMed ID: 25744245
[TBL] [Abstract][Full Text] [Related]
16. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals.
Liang S; Chen Z; Jiang G; Zhou Y; Liu Q; Su Q; Wei W; Du J; Wang H
Cancer Lett; 2017 Feb; 386():12-23. PubMed ID: 27836733
[TBL] [Abstract][Full Text] [Related]
17. GPER stabilizes F-actin cytoskeleton and activates TAZ via PLCβ-PKC and Rho/ROCK-LIMK-Cofilin pathway.
Wang Z; Sun L; Liang S; Liu ZC; Zhao ZY; Yang J; Wang D; Yang DQ
Biochem Biophys Res Commun; 2019 Aug; 516(3):976-982. PubMed ID: 31277940
[TBL] [Abstract][Full Text] [Related]
18. Selective GPER activation decreases proliferation and activates apoptosis in tumor Leydig cells.
Chimento A; Casaburi I; Bartucci M; Patrizii M; Dattilo R; Avena P; Andò S; Pezzi V; Sirianni R
Cell Death Dis; 2013 Aug; 4(8):e747. PubMed ID: 23907461
[TBL] [Abstract][Full Text] [Related]
19. GPER mediated estradiol reduces miR-148a to promote HLA-G expression in breast cancer.
Tao S; He H; Chen Q; Yue W
Biochem Biophys Res Commun; 2014 Aug; 451(1):74-8. PubMed ID: 25063027
[TBL] [Abstract][Full Text] [Related]
20. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
